Deception in clinical trials and its impact on recruitment and adherence of study participants
- PMID: 30138717
- PMCID: PMC6203693
- DOI: 10.1016/j.cct.2018.08.002
Deception in clinical trials and its impact on recruitment and adherence of study participants
Abstract
Deceptive practices by participants in clinical research are prevalent. It has been shown that as high as 75% of participants withheld information to avoid exclusion from studies. Self-reported adherence has been found to be largely inaccurate. Overcoming deception is a critical issue, since the safety of study participants, the integrity of research data and research resources are at risk. In this review article, we examine deception from the perspective of investigators conducting clinical trials; we describe the types (concealment, fabrication, drug holidays and collusion), prevalence, risks, and predictors of deception, and propose an approach to reduce the impact of deception, especially on adherence, in clinical trials.
Copyright © 2018 Elsevier Inc. All rights reserved.
Figures
References
-
- Laurie H, Shore D, Edelstein L, Epps O. House MD. Discs 1–6. Discs 1–6. [Millers Point, N.S.W: ]: Universal Pictures (Australasia) [distributor]; 2005.
-
- Stephens-Davidowitz S Everybody lies : big data, new data, and what the internet can tell us about who we really are. [United States: ]: HarperLuxe; 2017.
-
- Devine EG, Waters ME, Putnam M, Surprise C, O’Malley K, Richambault C, et al. Concealment and fabrication by experienced research subjects. Clinical trials (London, England). 2013;10(6):93548. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
